Sleep Disorders in Early Psychosis: New Research

October 8, 2018

Brian Miller, MD, PhD, MPH

Slideshow

Sleep disturbance-including shorter sleep time and lowered sleep quality-is associated with increased psychotic experiences. So what's new?

Related Videos

Related Content

A Look Back at the 2022 Annual Psychiatric Times® World CME Conference

October 3rd 2023

Treating ‘Morally Objectionable’ Patients

September 27th 2021

The Week in Review: September 25-29

September 30th 2023

More Than Postpartum Depression: Addressing Maternal Mental Health Through the Life Cycle

NDA Submitted for Investigational Muscarinic Antipsychotic in the Treatment of Schizophrenia

September 28th 2023

Cannabis and Schizophrenia: Implications in the Legalization Era

September 25th 2023

A Look Back at the 2022 Annual Psychiatric Times® World CME Conference

October 3rd 2023

Treating ‘Morally Objectionable’ Patients

September 27th 2021

The Week in Review: September 25-29

September 30th 2023

More Than Postpartum Depression: Addressing Maternal Mental Health Through the Life Cycle

NDA Submitted for Investigational Muscarinic Antipsychotic in the Treatment of Schizophrenia

September 28th 2023

Cannabis and Schizophrenia: Implications in the Legalization Era

September 25th 2023

A Look Back at the 2022 Annual Psychiatric Times® World CME Conference

October 3rd 2023

Treating ‘Morally Objectionable’ Patients

September 27th 2021

The Week in Review: September 25-29

September 30th 2023

More Than Postpartum Depression: Addressing Maternal Mental Health Through the Life Cycle

NDA Submitted for Investigational Muscarinic Antipsychotic in the Treatment of Schizophrenia

September 28th 2023

Cannabis and Schizophrenia: Implications in the Legalization Era

September 25th 2023

Related Content

Get ready for our upcoming virtual, interactive conference with some highlights from 2022.

A Look Back at the 2022 Annual Psychiatric Times® World CME Conference

October 3rd 2023

Treating ‘Morally Objectionable’ Patients

Treating ‘Morally Objectionable’ Patients

September 27th 2021

From connections between cannabis use and schizophrenia to some non-psychiatric medications that may worsen symptoms of major depression, here are highlights from the week in Psychiatric Times.

The Week in Review: September 25-29

September 30th 2023

More Than Postpartum Depression: Addressing Maternal Mental Health Through the Life Cycle

More Than Postpartum Depression: Addressing Maternal Mental Health Through the Life Cycle

The treatment, if approved, “will represent the first novel pharmacological approach to treating schizophrenia in several decades and provide a new treatment option for patients and their physicians.”

NDA Submitted for Investigational Muscarinic Antipsychotic in the Treatment of Schizophrenia

September 28th 2023

A look at the association between cannabis use and schizophrenia, as well as the need for comprehensive public health policies and education.

Cannabis and Schizophrenia: Implications in the Legalization Era

September 25th 2023

Terms and Conditions

Do Not Sell My Personal Information

Contact Info

2 Clarke Drive
Cranbury, NJ 08512

© 2023 MJH Life Sciences

All rights reserved.